Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 118

1.

Paroxysmal cough and left sacroiliac joint pain in a 50-year-old Caucasian man.

Proklou A, Bolaki M, Vassalou EE, Bibaki E, Vasarmidi E, Margaritopoulos GA, Karantanas AH, Tzanakis N, Antoniou KM.

Breathe (Sheff). 2018 Jun;14(2):e59-e67. doi: 10.1183/20734735.018818.

2.

New respiratory symptoms and lung imaging findings in a woman with polymyositis.

Bolaki M, Karagiannis K, Bertsias G, Mitrouska I, Tzanakis N, Antoniou KM.

Breathe (Sheff). 2018 Jun;14(2):e34-e39. doi: 10.1183/20734735.000118.

3.

miR-185 and miR-29a are similarly expressed in the bronchoalveolar lavage cells in IPF and lung cancer but common targets DNMT1 and COL1A1 show disease specific patterns.

Bibaki E, Tsitoura E, Vasarmidi E, Margaritopoulos G, Trachalaki A, Koutoulaki C, Georgopoulou T, Spandidos DA, Tzanakis N, Antoniou KM.

Mol Med Rep. 2018 May;17(5):7105-7112. doi: 10.3892/mmr.2018.8778. Epub 2018 Mar 19.

4.

Clinical applications of mesenchymal stem cells in chronic lung diseases.

Antoniou KM, Karagiannis K, Tsitoura E, Bibaki E, Lasithiotaki I, Proklou A, Spandidos DA, Tzanakis N.

Biomed Rep. 2018 Apr;8(4):314-318. doi: 10.3892/br.2018.1067. Epub 2018 Feb 16.

5.

Design, Rationale, Methodology, and Aims of a Greek Prospective Idiopathic Pulmonary Fibrosis Registry: Investigating Idiopathic Pulmonary Fibrosis in Greece (INDULGE IPF).

Bouros D, Daniil Z, Papakosta D, Antoniou KM, Markopoulou K, Kolilekas L, Konstantopoulos G, Papiris S; on behalf of the INDULGE IPF Study Group; INDULGE IPF Study Group.

Respiration. 2018 Mar 7;96(1):41-47. doi: 10.1159/000487244. [Epub ahead of print]

PMID:
29514162
6.

Upregulation of citrullination pathway: From Autoimmune to Idiopathic Lung Fibrosis.

Samara KD, Trachalaki A, Tsitoura E, Koutsopoulos AV, Lagoudaki ED, Lasithiotaki I, Margaritopoulos G, Pantelidis P, Bibaki E, Siafakas NM, Tzanakis N, Wells AU, Antoniou KM.

Respir Res. 2017 Dec 29;18(1):218. doi: 10.1186/s12931-017-0692-9.

7.

Towards a global initiative for fibrosis treatment (GIFT).

Molina-Molina M, Agusti A, Crestani B, Schwartz DA, Königshoff M, Chambers RC, Maher TM, Faner R, Mora AL, Rojas M, Antoniou KM, Sellares J.

ERJ Open Res. 2017 Dec 1;3(4). pii: 00106-2017. doi: 10.1183/23120541.00106-2017. eCollection 2017 Oct.

8.

The Genomic Detection of Usual Interstitial Pneumonia from Transbronchial Biopsy Tissue: A Dress Rehearsal for the Future?

Wells AU, Antoniou KM.

Ann Am Thorac Soc. 2017 Nov;14(11):1632-1633. doi: 10.1513/AnnalsATS.201708-670ED. No abstract available.

PMID:
29090993
9.

Treatment doses in idiopathic pulmonary fibrosis: The devil is in the detail.

Wells AU, Antoniou KM.

Respirology. 2018 Mar;23(3):244-245. doi: 10.1111/resp.13182. Epub 2017 Oct 20. No abstract available.

10.

Lung Ultrasonography in Patients With Idiopathic Pulmonary Fibrosis: Evaluation of a Simplified Protocol With High-Resolution Computed Tomographic Correlation.

Vassalou EE, Raissaki M, Magkanas E, Antoniou KM, Karantanas AH.

J Ultrasound Med. 2018 Mar;37(3):689-696. doi: 10.1002/jum.14406. Epub 2017 Sep 6.

PMID:
28877354
11.

Diagnostic accuracy of a clinical diagnosis of idiopathic pulmonary fibrosis: an international case-cohort study.

Walsh SLF, Maher TM, Kolb M, Poletti V, Nusser R, Richeldi L, Vancheri C, Wilsher ML, Antoniou KM, Behr J, Bendstrup E, Brown K, Calandriello L, Corte TJ, Cottin V, Crestani B, Flaherty K, Glaspole I, Grutters J, Inoue Y, Kokosi M, Kondoh Y, Kouranos V, Kreuter M, Johannson K, Judge E, Ley B, Margaritopoulos G, Martinez FJ, Molina-Molina M, Morais A, Nunes H, Raghu G, Ryerson CJ, Selman M, Spagnolo P, Taniguchi H, Tomassetti S, Valeyre D, Wijsenbeek M, Wuyts W, Hansell D, Wells A; IPF Project Consortium.

Eur Respir J. 2017 Aug 31;50(2). pii: 1700936. doi: 10.1183/13993003.00936-2017. Print 2017 Aug.

PMID:
28860269
12.

Impaired mRNA Expression of the Migration Related Chemokine Receptor CXCR4 in Mesenchymal Stem Cells of COPD Patients.

Karagiannis K, Proklou A, Tsitoura E, Lasithiotaki I, Kalpadaki C, Moraitaki D, Sperelakis I, Kontakis G, Antoniou KM, Tzanakis N.

Int J Inflam. 2017;2017:6089425. doi: 10.1155/2017/6089425. Epub 2017 Jul 19.

13.

Mesenchymal stem cell treatment for IPF-time for phase 2 trials?

Antoniou KM, Karagiannis K, Tsitoura E, Tzanakis N.

Lancet Respir Med. 2017 Jun;5(6):472-473. doi: 10.1016/S2213-2600(17)30180-7. Epub 2017 May 26. No abstract available.

PMID:
28664848
14.

Effect of Emphysema Extent on Serial Lung Function in Patients with Idiopathic Pulmonary Fibrosis.

Cottin V, Hansell DM, Sverzellati N, Weycker D, Antoniou KM, Atwood M, Oster G, Kirchgaessler KU, Collard HR, Wells AU.

Am J Respir Crit Care Med. 2017 Nov 1;196(9):1162-1171. doi: 10.1164/rccm.201612-2492OC.

PMID:
28657784
15.

Modified Lung Ultrasonographic Technique for Evaluation of Idiopathic Pulmonary Fibrosis: Lateral Decubitus Position.

Vassalou EE, Raissaki M, Magkanas E, Antoniou KM, Karantanas AH.

J Ultrasound Med. 2017 Dec;36(12):2525-2532. doi: 10.1002/jum.14297. Epub 2017 Jun 28.

PMID:
28656715
16.

Clinical highlights from the 2016 European Respiratory Society International Congress.

Kahn N, Fregonese L, Barrecheguren M, Franssen FME, Grgic A, Gompelmann D, Bibaki E, Antoniou KM, Kocks JWH, Pinnock H, Herth F.

ERJ Open Res. 2017 Apr 12;3(2). pii: 00147-2016. doi: 10.1183/23120541.00147-2016. eCollection 2017 Apr.

17.

Controversies in Fibrosis and Emphysema.

Antoniou KM, Bibaki E, Margaritopoulos GA.

Arch Bronconeumol. 2017 May;53(5):231-232. doi: 10.1016/j.arbres.2017.02.003. Epub 2017 Mar 23. English, Spanish. No abstract available.

18.

Reply: Is a Trial of Vitamin K Antagonists and Bisphosphonates Possible in IPF?

Margaritopoulos GA, Antoniou KM.

Am J Respir Crit Care Med. 2017 Jan 15;195(2):271-272. doi: 10.1164/rccm.201608-1636LE. No abstract available.

PMID:
28084829
19.

Comorbidities in interstitial lung diseases.

Margaritopoulos GA, Antoniou KM, Wells AU.

Eur Respir Rev. 2017 Jan 3;26(143). pii: 160027. doi: 10.1183/16000617.0027-2016. Print 2017 Jan. Review.

20.

Reply: Heparin versus Warfarin in Interstitial Pulmonary Fibrosis: The Quest for the Right Anticoagulant Continues.

Margaritopoulos GA, Antoniou KM.

Am J Respir Crit Care Med. 2017 Jan 1;195(1):142-143. doi: 10.1164/rccm.201606-1323LE. No abstract available.

PMID:
28035862
21.

MiR-185/AKT and miR-29a/collagen 1a pathways are activated in IPF BAL cells.

Tsitoura E, Wells AU, Karagiannis K, Lasithiotaki I, Vasarmidi E, Bibaki E, Koutoulaki C, Sato H, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM.

Oncotarget. 2016 Nov 15;7(46):74569-74581. doi: 10.18632/oncotarget.12740.

22.

Reply.

Margaritopoulos GA, Antoniou KM, Denton CP, Wells AU.

Arthritis Rheumatol. 2017 Jan;69(1):240-241. doi: 10.1002/art.39930. No abstract available.

23.

Toll-like receptors and autophagy in interstitial lung diseases.

Margaritopoulos GA, Lasithiotaki I, Antoniou KM.

Eur J Pharmacol. 2017 Aug 5;808:28-34. doi: 10.1016/j.ejphar.2016.09.032. Epub 2016 Sep 27. Review.

PMID:
27687957
24.

Aberrant expression of miR-21, miR-376c and miR-145 and their target host genes in Merkel cell polyomavirus-positive non-small cell lung cancer.

Lasithiotaki I, Tsitoura E, Koutsopoulos A, Lagoudaki E, Koutoulaki C, Pitsidianakis G, Spandidos DA, Siafakas NM, Sourvinos G, Antoniou KM.

Oncotarget. 2016 Aug 11;8(68):112371-112383. doi: 10.18632/oncotarget.11222. eCollection 2017 Dec 22.

25.

Pirfenidone in the treatment of idiopathic pulmonary fibrosis: an evidence-based review of its place in therapy.

Margaritopoulos GA, Vasarmidi E, Antoniou KM.

Core Evid. 2016 Jul 1;11:11-22. doi: 10.2147/CE.S76549. eCollection 2016. Review.

26.

Acute Exacerbation of Idiopathic Pulmonary Fibrosis. An International Working Group Report.

Collard HR, Ryerson CJ, Corte TJ, Jenkins G, Kondoh Y, Lederer DJ, Lee JS, Maher TM, Wells AU, Antoniou KM, Behr J, Brown KK, Cottin V, Flaherty KR, Fukuoka J, Hansell DM, Johkoh T, Kaminski N, Kim DS, Kolb M, Lynch DA, Myers JL, Raghu G, Richeldi L, Taniguchi H, Martinez FJ.

Am J Respir Crit Care Med. 2016 Aug 1;194(3):265-75. doi: 10.1164/rccm.201604-0801CI. Review.

27.

Medical Therapy in Idiopathic Pulmonary Fibrosis.

Antoniou KM, Wuyts W, Wijsenbeek M, Wells AU.

Semin Respir Crit Care Med. 2016 Jun;37(3):368-77. doi: 10.1055/s-0036-1582010. Epub 2016 May 27. Review.

PMID:
27231861
28.

Can Warfarin Be Used in the Treatment of Pulmonary Embolism in Idiopathic Pulmonary Fibrosis?

Margaritopoulos GA, Antoniou KM.

Am J Respir Crit Care Med. 2016 Apr 1;193(7):810-1. doi: 10.1164/rccm.201511-2267LE. No abstract available.

PMID:
27035785
29.

NLRP3 inflammasome expression in idiopathic pulmonary fibrosis and rheumatoid lung.

Lasithiotaki I, Giannarakis I, Tsitoura E, Samara KD, Margaritopoulos GA, Choulaki C, Vasarmidi E, Tzanakis N, Voloudaki A, Sidiropoulos P, Siafakas NM, Antoniou KM.

Eur Respir J. 2016 Mar;47(3):910-8. doi: 10.1183/13993003.00564-2015. Epub 2016 Jan 7.

30.

Combined Pulmonary Fibrosis and Emphysema in Scleroderma-Related Lung Disease Has a Major Confounding Effect on Lung Physiology and Screening for Pulmonary Hypertension.

Antoniou KM, Margaritopoulos GA, Goh NS, Karagiannis K, Desai SR, Nicholson AG, Siafakas NM, Coghlan JG, Denton CP, Hansell DM, Wells AU.

Arthritis Rheumatol. 2016 Apr;68(4):1004-12. doi: 10.1002/art.39528.

31.

Idiopathic pulmonary fibrosis and lung cancer: a clinical and pathogenesis update.

Antoniou KM, Tomassetti S, Tsitoura E, Vancheri C.

Curr Opin Pulm Med. 2015 Nov;21(6):626-33. doi: 10.1097/MCP.0000000000000217. Review.

PMID:
26390339
32.

Smoking and interstitial lung diseases.

Margaritopoulos GA, Vasarmidi E, Jacob J, Wells AU, Antoniou KM.

Eur Respir Rev. 2015 Sep;24(137):428-35. doi: 10.1183/16000617.0050-2015. Review.

33.

New Treatments for Idiopathic Pulmonary Fibrosis: 'Die Another Day' if Diagnosed Early?

Antoniou KM, Symvoulakis EK, Anyfantakis D, Wells AU.

Respiration. 2015;90(4):352. doi: 10.1159/000436980. Epub 2015 Jul 31. No abstract available.

34.

An official European Respiratory Society/American Thoracic Society research statement: interstitial pneumonia with autoimmune features.

Fischer A, Antoniou KM, Brown KK, Cadranel J, Corte TJ, du Bois RM, Lee JS, Leslie KO, Lynch DA, Matteson EL, Mosca M, Noth I, Richeldi L, Strek ME, Swigris JJ, Wells AU, West SG, Collard HR, Cottin V; “ERS/ATS Task Force on Undifferentiated Forms of CTD-ILD”.

Eur Respir J. 2015 Oct;46(4):976-87. doi: 10.1183/13993003.00150-2015. Epub 2015 Jul 9.

35.

Smoking-related idiopathic interstitial pneumonia: A review.

Margaritopoulos GA, Harari S, Caminati A, Antoniou KM.

Respirology. 2016 Jan;21(1):57-64. doi: 10.1111/resp.12576. Epub 2015 Jul 2. Review.

36.

Idiopathic pulmonary fibrosis and sleep disorders: no longer strangers in the night.

Schiza S, Mermigkis C, Margaritopoulos GA, Daniil Z, Harari S, Poletti V, Renzoni EA, Torre O, Visca D, Bouloukaki I, Sourvinos G, Antoniou KM.

Eur Respir Rev. 2015 Jun;24(136):327-39. doi: 10.1183/16000617.00009114. Review.

37.

Clinical highlights: messages from Munich.

Vogiatzis I, Marvisi M, Coolen J, Gasparini S, Antoniou KM, Stallberg B, Bjerg A, Herth FJ, Clini E.

ERJ Open Res. 2015 May 15;1(1). pii: 00002-2015. eCollection 2015 May.

38.

Combination therapy: the future of management for idiopathic pulmonary fibrosis?

Wuyts WA, Antoniou KM, Borensztajn K, Costabel U, Cottin V, Crestani B, Grutters JC, Maher TM, Poletti V, Richeldi L, Vancheri C, Wells AU.

Lancet Respir Med. 2014 Nov;2(11):933-942. doi: 10.1016/S2213-2600(14)70232-2. Epub 2014 Nov 3. Review. Erratum in: Lancet Respir Med. 2015 Jan;3(1):e2.

PMID:
25439569
39.

The prognostic value of the GAP model in chronic interstitial lung disease: the quest for a staging system.

Wells AU, Antoniou KM.

Chest. 2014 Apr;145(4):672-674. doi: 10.1378/chest.13-2908. No abstract available.

PMID:
24687701
40.

Interstitial lung disease in systemic sclerosis.

Wells AU, Margaritopoulos GA, Antoniou KM, Denton C.

Semin Respir Crit Care Med. 2014 Apr;35(2):213-21. doi: 10.1055/s-0034-1371541. Epub 2014 Mar 25. Review.

PMID:
24668536
41.

Interstitial lung disease.

Antoniou KM, Margaritopoulos GA, Tomassetti S, Bonella F, Costabel U, Poletti V.

Eur Respir Rev. 2014 Mar 1;23(131):40-54. doi: 10.1183/09059180.00009113. Review.

42.

An integrated clinicoradiological staging system for pulmonary sarcoidosis: a case-cohort study.

Walsh SL, Wells AU, Sverzellati N, Keir GJ, Calandriello L, Antoniou KM, Copley SJ, Devaraj A, Maher TM, Renzoni E, Nicholson AG, Hansell DM.

Lancet Respir Med. 2014 Feb;2(2):123-30. doi: 10.1016/S2213-2600(13)70276-5. Epub 2014 Jan 15.

43.

Early diagnosis of IPF: time for a primary-care case-finding initiative?

Antoniou KM, Symvoulakis EK, Margaritopoulos GA, Lionis C, Wells AU.

Lancet Respir Med. 2014 Jan;2(1):e1. doi: 10.1016/S2213-2600(13)70283-2. No abstract available.

PMID:
24461905
44.

Detection and genotype analysis of human papillomavirus in non-small cell lung cancer patients.

Sarchianaki E, Derdas SP, Ntaoukakis M, Vakonaki E, Lagoudaki ED, Lasithiotaki I, Sarchianaki A, Koutsopoulos A, Symvoulakis EK, Spandidos DA, Antoniou KM, Sourvinos G.

Tumour Biol. 2014 Apr;35(4):3203-9. doi: 10.1007/s13277-013-1419-2. Epub 2013 Dec 6.

PMID:
24310500
45.

Acute exacerbations of idiopathic pulmonary fibrosis.

Antoniou KM, Wells AU.

Respiration. 2013;86(4):265-74. doi: 10.1159/000355485. Epub 2013 Oct 19. Review.

46.

Differential telomerase expression in idiopathic pulmonary fibrosis and non-small cell lung cancer.

Antoniou KM, Samara KD, Lasithiotaki I, Margaritopoulos GA, Soufla G, Lambiri I, Giannarakis I, Drositis I, Spandidos DA, Siafakas NM.

Oncol Rep. 2013 Dec;30(6):2617-24. doi: 10.3892/or.2013.2753. Epub 2013 Sep 25.

47.

Pharmacological treatment of idiopathic pulmonary fibrosis: from the past to the future.

Antoniou KM, Margaritopoulos GA, Siafakas NM.

Eur Respir Rev. 2013 Sep 1;22(129):281-91. doi: 10.1183/09059180.00002113. Review.

48.

Smoking-related emphysema is associated with idiopathic pulmonary fibrosis and rheumatoid lung.

Antoniou KM, Walsh SL, Hansell DM, Rubens MR, Marten K, Tennant R, Hansel T, Desai SR, Siafakas NM, du Bois RM, Wells AU.

Respirology. 2013 Nov;18(8):1191-6. doi: 10.1111/resp.12154.

PMID:
23819865
49.

A patient presenting with bilateral lung lesions, pleural effusion, and proteinuria.

Samara KD, Papadogiannis G, Nicholson AG, Magkanas E, Stylianou K, Siafakas N, Antoniou KM.

Case Rep Med. 2013;2013:489362. doi: 10.1155/2013/489362. Epub 2013 May 9.

50.

Molecular pathological findings of Merkel cell polyomavirus in lung cancer: a possible etiopathogenetic link?

Antoniou KM, Lasithiotaki I, Symvoulakis E, Derdas SP, Psaraki A, Spandidos DA, Stathopoulos EN, Siafakas NM, Sourvinos G.

Int J Cancer. 2013 Dec 15;133(12):3016-7. doi: 10.1002/ijc.28308. Epub 2013 Jun 29. No abstract available.

Supplemental Content

Loading ...
Support Center